AMS_case J&J

download AMS_case J&J

of 18

Transcript of AMS_case J&J

  • 8/7/2019 AMS_case J&J

    1/18

    Group 3: Practical Application

  • 8/7/2019 AMS_case J&J

    2/18

    ` The Company

    ` The Market Environment

    ` The past situation

    ` Implementing Innovation` Process & Resource Allocation

    ` Innovation through synergy

    ` William C. Weldon

    ` Examples for J&Js performance

    ` Core success concept

  • 8/7/2019 AMS_case J&J

    3/18

    ` Traditional 117 (2006) years

    old company

    ` Consists of 204 business

    organization` Largest health company in

    the USA

    ` 10% earnings growth per

    year

    ` Since the 1980 stock priceincreased by 20 times

  • 8/7/2019 AMS_case J&J

    4/18

    0.00%

    20.00%

    40.00%

    0.00%

    80.00%

    Share of Sales

    Share ofOperating Profits

  • 8/7/2019 AMS_case J&J

    5/18

    ` Companies Strenths High Economies of scale

    High Economies of scope

    market dominating

    Scientific expertise Marketing savvy

    Continuous Innovation or acquisition of innovations

    Heritage (tradition of quality)

    Acquisitioned power to create synergies

  • 8/7/2019 AMS_case J&J

    6/18

    ` Depended on scientific innovation

    ` 500-stock index decreased by 28.1%

    ` J&J increased by 19.4%

    ` Drug business is slowing down its growth

    ` Less innovations

  • 8/7/2019 AMS_case J&J

    7/18

    ` Highly decentralized Organizational Structure` Near-total Autonomy of Business Unites` highly competitive because of theentrepreneurial

    attitude

  • 8/7/2019 AMS_case J&J

    8/18

    ` Coordinating the Independent Businesses Delivering idea to synergy

    ` Putting J&Js famed autonomy at risk

    ` Cultivating alliances

  • 8/7/2019 AMS_case J&J

    9/18

    ` Foster communication

    ` Emphasize interdisciplinary collaboration

    ` Combination of drugs devices and diagnostics

    ` High advantage of J&J in achieving this integration` Keeping up theentrepreneurial attitude

  • 8/7/2019 AMS_case J&J

    10/18

    ` Weldon delegates crucial decisions to R&D

    ` Decisive power is by the Business Unit Managers

    ` Creating the idea of autonomy

    ` Disease Experts meet quarterly for past 5 years` Two groups focused on two diseases

    ` Strategy presentation after six month

    ` Example: The diagnostics team develops a test that

    the R&D folks could use to predict which patients willbenefit from a experimental cancer therapy

  • 8/7/2019 AMS_case J&J

    11/18

    Pharmaceuticaloperation

    Pharmaceuticaloperation

    Drug DeliveryOperation

    Drug DeliveryOperation

    ImprovedDrugs

    epilepsy drug +obesity treatment

    ImprovedDrugs

    epilepsy drug +obesity treatment

    DiagnosticUnit

    DiagnosticUnit

    Drugresearchers

    Drugresearchers

    NewMedicalTests

    NewMedicalTests

    ExistingProductsExistingProducts

    SuperiorValue

    SuperiorValue

    SubstantialInnovation

    (LiquidBandage)

    SubstantialInnovation

    (LiquidBandage)

  • 8/7/2019 AMS_case J&J

    12/18

    ` SimpleFamily background

    ` Major in Biology

    ` Self made man, worked his way up

    ` Persuasive

    ` Casual` Sporty

    ` Visionary

    ` Ambitious

    Creating a innovation favoringCulture

  • 8/7/2019 AMS_case J&J

    13/18

    Demanding GoalsDemanding Goals

    If you werent putting your weight you were gone

    Nice job. Why couldnt it have been 25% higher

    In t

    his gam

    ethe

    re

    are

    two strikes

    Positive reinforcementPositive reinforcement

    Higher bonuses forhis managers

    Closed up the shop for a day of rest

    Som

    etim

    es it is b

    etter to b

    eg forgiv

    eness t

    hen ask p

    ermission

    The CriticsThe Critics

    He is an intimidator and a dominator

  • 8/7/2019 AMS_case J&J

    14/18

    ` Pops open arteries after angioplasty Catheter with balloon at the tip to open arteries The balloon popping open the stent, catheter and balloon are

    removed, leaving the stent in place Drug of the stent is released in the blood vessels wall over time

    ` Teams from the drug business and the device operationcollaborating` Weldon got monthly feedback` Experts were working mostly independent/empowerment of the

    divisions

  • 8/7/2019 AMS_case J&J

    15/18

    ` Procrit J&Js biggest selling product

    ` Stagnating growth because of Aransep for Amgen

    Inc.

    ` The European version had to face sideeffects` Stronger competition

    ` Growth declined from 20% to 2%

    ` Also the drug Remicade under competition

    ` Weldon downplays the threat by introducing

    a innovational use of the product

  • 8/7/2019 AMS_case J&J

    16/18

  • 8/7/2019 AMS_case J&J

    17/18

    ` Strategic Acquisitions

    ` Innovation favoring culture

    ` Autonomic and coordinated business units

    ` Constantly adding innovations` Innovating existing products by adding value

  • 8/7/2019 AMS_case J&J

    18/18